Chaobal Md Harshvardhan is categorized under Internal Medicine Doctors in New York City, NY and active since 2007.
Chaobal Md Harshvardhan was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Harshvardhan Chaobal at the company’s single location by writing to 1 Gustave L Levy Place, New York City, New York NY 10029 or by phoning (212) 241-6426. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chaobal Md Harshvardhan |
| Contact Person: | Harshvardhan Chaobal |
| Address: | 1 Gustave L Levy Place, New York City, New York 10029 |
| Phone Number: | (212) 241-6426 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Chaobal Md Harshvardhan was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Harshvardhan Chaobal for inquiries that concern Chaobal Md Harshvardhan by calling the company number (212) 241-6426, as your correspondence is most welcome. Additionally, the physical location of the single location of Chaobal Md Harshvardhan can be found at the coordinates 40.789424,-73.954457 as well as the street address 1 Gustave L Levy Place in New York City, New York 10029.
For its online presence, you may visit Chaobal Md Harshvardhan’s website at and engage with its social media outlets through on Twitter and on Facebook.